candesartan cilexetil has been researched along with Infant, Newborn, Diseases in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quinlan, S | 1 |
| Merino-Serrais, P | 1 |
| Di Grande, A | 1 |
| Dussmann, H | 1 |
| Prehn, JHM | 1 |
| Ní Chonghaile, T | 1 |
| Henshall, DC | 1 |
| Jimenez-Mateos, EM | 1 |
1 other study available for candesartan cilexetil and Infant, Newborn, Diseases
| Article | Year |
|---|---|
The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia.
Topics: Animals; Anti-Inflammatory Agents; Benzimidazoles; Biphenyl Compounds; Disease Models, Animal; Hippo | 2019 |